Blog

Koninklijke Philips (ENXTAM:PHIA) has experienced some shifts in stock performance over the past month, catching the attention of investors who are looking for companies navigating dynamic markets. Shares have moved up nearly 2% in the past month.

See our latest analysis for Koninklijke Philips.

After a challenging twelve months, Koninklijke Philips has been making up some ground, most recently with a positive 14.4% 90-day share price return. While the past year’s total shareholder return sits in negative territory, upside momentum has picked up, suggesting a shift in risk sentiment and possibly renewed confidence in the company’s growth potential.

If you’re interested in discovering what else is trending in healthcare and medtech, take the next step and check out See the full list for free.

With Philips trading nearly 10% below analyst targets and showing strong recent gains, the key question is whether the market is still undervaluing its long-term prospects or if future growth is now fully reflected in the price.

Philips trades at a price-to-earnings (P/E) ratio of 135.7x, which is far higher than both the sector and peer averages. The latest close of €24.26 places it firmly in the expensive camp relative to comparable medical equipment companies in Europe.

The price-to-earnings ratio measures what investors are willing to pay today for each euro of the company’s earnings. A high P/E can reflect optimism about future growth or profitability improvements, but it can also suggest overenthusiasm if not backed by strong fundamentals.

The implication here is clear: the market is pricing in ambitious profit growth for Philips, likely in response to its return to profitability and positive near-term momentum. However, when compared to the European industry average P/E of 29.1x and the peer average of 31.6x, Philips’ premium suggests investors expect more rapid earnings expansion, margin gains, or both.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Earnings of 135.7x (OVERVALUED)

However, still, a slowdown in revenue growth or any stumbles in profitability could quickly reverse recent optimism and put pressure on Philips’ lofty valuation.

Find out about the key risks to this Koninklijke Philips narrative.

While Philips looks overvalued based on its price-to-earnings ratio, our DCF model presents a different perspective. The stock is trading at a 52.9% discount to our estimated fair value of €51.56, which suggests potential upside. Does this fundamental valuation challenge the market’s skepticism?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Koninklijke Philips for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

If you would like to analyze the numbers with your own perspective or dig deeper into the details, it’s quick and easy to craft your own narrative in minutes. Do it your way

A great starting point for your Koninklijke Philips research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Staying ahead means seeking smart opportunities beyond a single stock. Uncover fresh investment angles and gain an edge with cutting-edge screeners built for results.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include PHIA.enxtam.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com